Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
Lawrence E Goldfinger,1,2 Seunghyung Lee1 1Department of Anatomy and Cell Biology, The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA; 2Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA Abstract: Multidrug resistance in lung ca...
Guardado en:
Autores principales: | Goldfinger LE, Lee S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8ba42b657b9401fb41fbc358a38b57e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013) -
Emerging treatment options in the management of non-small cell lung cancer
por: Filosso PL, et al.
Publicado: (2011) -
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
por: Dana S. Neel, et al.
Publicado: (2017) -
Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012) -
Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga N, et al.
Publicado: (2015)